High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.
about
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo StudyNovel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Sirtuin 1: A Target for Kidney Diseases.Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulationNeferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic miceCurcumin, inflammation, and chronic diseases: how are they linked?Invited review: mesenchymal progenitor cells in intramuscular connective tissue development.The expression of Smad signaling pathway in myocardium and potential therapeutic effects.Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy.Pathophysiological Fundamentals of Diabetic Cardiomyopathy.Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling.Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes MellitusRegulation of Sirtuin-Mediated Protein Deacetylation by Cardioprotective Phytochemicals.Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.Advanced glycation end-products accelerate the cardiac aging process through the receptor for advanced glycation end-products/transforming growth factor-β-Smad signaling pathway in cardiac fibroblasts.p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis.
P2860
Q33851976-8E87950E-AF01-4A80-9509-203CBD7579C7Q34531894-FF538619-EB4A-4980-8288-1BC918D520A7Q35707150-828232CC-F02D-47EA-AB38-B1409AA1A718Q36246346-BB93C373-AC00-4F1E-A615-FCD4C98A5B7FQ37278532-3DC8A967-9780-40FF-83F8-89F843A4AD31Q37641668-7D6F464F-591C-445D-BD98-87B3B0DCD522Q38501499-56462158-4A64-4236-AC54-4D314483C05BQ38583172-D5F9F78D-B3C6-4752-A255-9032BB4E02C7Q39008931-44E1ED9C-F6F2-4FAB-A965-95389B4404B6Q39018712-C8488D8D-F5FB-492C-8DCE-2507CCA1779CQ39195672-A44B3AB7-63EE-47B2-8985-F5E2F55233D2Q41593391-205B5746-AE7A-47B4-AF60-D84C28DF951EQ41643658-CFE6BAFF-0A66-4C8E-B1C3-52DD19AA69E6Q45827486-835F8B88-9D78-4B8C-A418-1BAE13D250BFQ48635091-C0E23F5F-F8CD-4C45-A26F-B34D52107ECAQ50585083-D6E6E82F-A518-486A-BE2B-30497669A4D5Q55358970-06855B1E-6364-4C97-A2A0-EF5EF41A7E9C
P2860
High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
High glucose induces Smad acti ...... diac fibrosis and hypertrophy.
@en
type
label
High glucose induces Smad acti ...... diac fibrosis and hypertrophy.
@en
prefLabel
High glucose induces Smad acti ...... diac fibrosis and hypertrophy.
@en
P2093
P2860
P356
P1476
High glucose induces Smad acti ...... diac fibrosis and hypertrophy.
@en
P2093
Andrew Advani
Antoinette Bugyei-Twum
Darren J Kelly
Kerri Thai
Kim A Connelly
Suzanne L Advani
Yuan Zhang
P2860
P2888
P356
10.1186/1475-2840-13-89
P407
P577
2014-05-05T00:00:00Z
P5875
P6179
1028568023